Eurasian Harm Reduction Network - EHRN Eurasian Harm Reduction Network (EHRN) / Евразийская сеть снижения вреда (ЕССВ)

Quitting while not ahead: The Global Fund’s retrenchment and the looming crisis for harm reduction in Eastern Europe and Central Asia
May 09, 2012
Report by Eurasian Harm Reduction Network (EHRN) developed in the lead-up to the 26th Global Fund Board meeting, which is taking place in Geneva on May 10-11, 2012. The report assesses the consequences of the sharp reduction in donor support that forced the Global Fund to halt new funding and to impose cost-cutting measures.

Over the last decade, the Global Fund has played a unique and indispensable role in responding to the HIV epidemic among people who use drugs in Eastern Europe and Central Asia (EECA). From 2002 to 2009, it approved $263 million for harm reduction in EECA alone—more than all other international sources combined.

Harm reduction Harm reduction encompasses strategies and interventions based on public health and human rights aimed at the reduction of negative consequences of drug use, including transmissions of infection, mortality and others.	Drug policy Drug policies should be designed to promote the health, welfare, and rights of people who use drugs and the communities they live in and be based on evidence of effectiveness and cost effectiveness.	Opioid substitution therapy Substitution treatment is a drug dependency treatment option which has proven to reduce HIV transmission, improve adherence to ARV drugs, reduce overdose mortality and support social integration.

Hepatitis C	Prisons	HIV
Overdose	Special groups	Stigma & discrimination

Harm reduction